The latest from the stream

Upstream Medical Technologies, a leading deep-tech company focused on developing innovative solutions for heart disease, announced today that it has closed a significant capital round to further advance its frontline diagnostic tests for cardiac diseases.

Upstream is pleased to regain access to its laboratories as New Zealand exits the Level 4 and 3 lockdowns that commenced on 25 March.

Upstream’s board is pleased to announce that Kieran Jina has been appointed to the role of Chief Executive Officer of the company.

Upstream announces the close of a convertible note round that sought a minimum of NZ$1.2m and a target of NZ$1.8m led by Pacific Channel.

Upstream is pleased to announce that Kieran Jina has been appointed as Chief Operating Officer of Upstream in a full-time capacity.

Dr Frank Peacock is an internationally known Emergency Medicine physician specialising in Cardiovascular disease care.

Upstream Medical Technologies has developed a biomarker-based diagnostic test to rule out the risk of imminent heart attack.

Investment secured in a record four days.

Early-stage Upstream fills oversubscribed funding round in four days.

Kiwi investors help local tech firm on path to improving diagnosis prospects

Upstream Medical Technologies Ltd, has just closed a bridging round fully subscribed and over subscribed.

Dr Ruth Appleby presents at NZ BIO Conference.

Dr Ross Walker is an eminent practising cardiologist with over 35 years experience as a clinician.

We will be at BIO International Convention June 19-22 in San Diego.